Research
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j5058 (Published 28 November 2017) Cite this as: BMJ 2017;359:j5058
Data supplement
Web Extra
- Data Supplement - Appendix: Supplementary materials
- Data Supplement - Appendix: Supplementary materials
- Data Supplement - Appendix: Supplementary materials
- Data Supplement - Appendix: Supplementary materials
- Data Supplement - Appendix: Supplementary materials
- Data Supplement - Appendix: Supplementary materials
- Data Supplement - Appendix: Supplementary materials
Related articles
- Correction Published: 04 December 2017; BMJ 359 doi:10.1136/bmj.j5631
- Correction Published: 23 May 2018; BMJ 361 doi:10.1136/bmj.k2295
- Feature Published: 28 September 2016; BMJ 354 doi:10.1136/bmj.i5131
- Research Published: 05 November 2012; BMJ 345 doi:10.1136/bmj.e7097
- Research Methods & Reporting Published: 18 October 2011; BMJ 343 doi:10.1136/bmj.d5928
- Paper Published: 01 July 2004; BMJ 329 doi:10.1136/bmj.329.7456.15
- Practice Published: 30 August 2024; BMJ 386 doi:10.1136/bmj-2024-079520
See more
- Patients with asthma or heart disease should avoid incense sticks and other airborne pollutants, says CMOBMJ June 03, 2025, 389 r1146; DOI: https://doi.org/10.1136/bmj.r1146
- Why are UK cardiovascular deaths in under 65s rising again?BMJ May 19, 2025, 389 r1015; DOI: https://doi.org/10.1136/bmj.r1015
- Prescribing parkrun: medicalising a walk in the parkBMJ April 08, 2025, 389 r670; DOI: https://doi.org/10.1136/bmj.r670
- GPs can prescribe tirzepatide to priority patient groups from JuneBMJ April 02, 2025, 389 r665; DOI: https://doi.org/10.1136/bmj.r665
- Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reportsBMJ February 12, 2025, 388 r287; DOI: https://doi.org/10.1136/bmj.r287
Cited by...
- Practical Prescribing: Direct oral anticoagulants
- Disparities in the real-world prescription pattern of oral anticoagulants for US Medicare beneficiaries: a geospatial analysis
- Temporal trends in mortality and causes of death in patients with incident atrial fibrillation: a nationwide register study from 2010 to 2018
- Pharmacist-led interventions in optimising the use of oral anticoagulants in patients with atrial fibrillation in general practice in England: a retrospective observational study
- Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort
- Investigation into financial conflicts of interest and screening for atrial fibrillation in the UK: a cross-sectional study
- Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study
- Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial
- Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis
- Long-term mortality of patients ablated for atrial fibrillation: a retrospective, population-based epidemiological study in Apulia, Italy
- Atrial fibrillation: NICE 2021 update and the focus on anticoagulation
- Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis
- Risk of stroke and other thromboembolic complications after interruption of DOAC therapy compared with warfarin therapy in patients with atrial fibrillation: a retrospective cohort analysis
- Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case-control study
- Multilevel and Quasi Monte Carlo methods for the calculation of the Expected Value of Partial Perfect Information
- Combining clinical and polygenic risk improves stroke prediction among individuals with atrial fibrillation
- Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation
- The real prize of direct oral anticoagulant blockbuster
- Cost-effectiveness of antithrombotic agents for atrial fibrillation in older adults at risk for falls: a mathematical modelling study
- Uptake of direct oral anticoagulants in primary care: an ecological and economic study
- Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology
- Choosing antithrombotics for atrial fibrillation in primary care
- Anticoagulants Safety and Effectiveness in General Practice: A Nationwide Prospective Cohort Study
- Network meta-analysis for diagnostic tests
- Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves
- Periendoscopic management of direct oral anticoagulants: a prospective cohort study
- Atrial fibrillation and stroke: a practical guide
- Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis
- Reversing anti-factor Xa agents and the unmet needs in trauma patients
- Protective effects of oral anticoagulants on cerebrovascular diseases and cognitive impairment in patients with atrial fibrillation: protocol for a multicentre, prospective, observational, longitudinal cohort study (Strawberry study)
- Dabigatran persistence and adherence in New Zealand: a nationwide retrospective observational study